ArticleAsian Pacific journal of cancer prevention : APJCP2021

Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro.

Razieh Amini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.